A five-month-old entire female crossbreed dog weighing 14.6 kg (32.2 lb) was presented for further investigations of insidious onset of abdominal pain, apparent bilateral pelvic limb weakness, reluctance to walk and intermittent vomiting and diarrhoea for a duration of six weeks prior to referral. Initially, clinical signs were managed with symptomatic therapies by the dog’s primary veterinarian. Due to the persistence and progressive worsening of observed signs, the dog’s primary veterinarian performed abdominal radiography and an abdominal ultrasound examination which identified a large 60 mm × 80 mm ovoid structure in the mid abdominal region. The primary veterinarian suspected mild inflammation of the surrounding mesentery and the remainder of the examination was considered normal at this time. An ultrasound-guided fluid sample was obtained from the structure and cytological analysis identified a proteinaceous fluid with necrotic cellular material and mild, non-septic neutrophilic inflammation with moderate to marked accumulation of uniformly blue-black pigment.
The patient was bright, alert and responsive during the examination, and all clinical parameters were within normal reference ranges. A non-reducible, non-painful umbilical hernia was identified. She displayed no obvious signs of pain or discomfort on abdominal palpation. The previously described abdominal cystic structure was not palpable on abdominal palpation.
Hematology and biochemistry analysis were grossly unremarkable and identified mild elevations in urea 15 mmol/l (3.6–8.6 mmol/l), creatinine 256 mmol/l (20-120 mmol/l), alkaline phosphatase (ALP) 167 U/L (0-82 U/L), alanine aminotransferase (ALT) 83 U/L (0–36 U/L) and amylase 2642 U/L (400–1300 U/L). Urinalysis of a sample obtained by cystocentesis identified epithelial 1+, red blood cells 1+, white blood cells 4+, and was therefore considered normal.
A computed tomographic (CT) examination was performed under general anaesthesia. A combination of butorphanol 0.3 mg/kg (0.13 mg/lb) (torbugesic 10 mg/ml)Footnote 1 and medetomidine hydrochloride 1μg/kg (0.0004 mg/lb) (sedastart 1 mg/ml,)Footnote 2 were administered intravenously as a premedication. The patient was induced with Propofol 3 mg/kg (1.3 mg/lb) (propofol-lipuro 10 mg/ml)Footnote 3 and a size 8 endotracheal tube was placed to allow maintenance of inhalant anaesthesia via sevoflurane in oxygen. Abdominal CT was performed with a 16-slice helical CT scanner (SOMATOM Scope; Siemens, Erlangen, Germany); pre- and post-intravenous contrast administration (ioversol 600 mg/kg (272 mg/lb) (optiray 300 mg/ml)).Footnote 4 A large ovoid structure measuring 156 mm in length, 95 mm in height and 89 mm in width was identified, which was centrally fluid attenuating and non-contrast enhancing. It had a thin, approximately 3 mm thickness soft tissue and contrast enhancing margin, and was centered within the midventral abdomen. The mass extended from immediately caudal to the level of the gastric body (at the level of the T12 vertebral body and caudally to the level of the L3 vertebral body. At its maximum cross-sectional area (CSA) at the level of the L2-L3 intervertebral disc space, the mass occupied 75% the CSA of the abdominal cavity (Fig. 1). There was a focal thickening of the dorsal aspect of the wall of the mass measuring approximately 40 mm length, 47 mm height and 29 mm width, with one well defined ovoid (13 mm × 8.4 mm diameter) fluid attenuating structure located within the cranial aspect of this focally thickened tissue. A second focal nodular ovoid soft tissue attenuating and contract enhancing structure (9 mm × 6.3 mm) was located at the left ventrolateral margin of the large mass. The mass border effaced the ventral margin of the left limb of the pancreas. The mass displaced the left kidney caudally to the level of the L4-L6 vertebral bodies and displaced multiple segments of the small intestine caudally. The transverse colon was displaced dorsally. Multiple jejunal lymph nodes were moderately enlarged, up the 14 mm, but remained regularly marginated.
A sample of fluid was obtained from the structure which had a moderate cellularity in a moderately-basophilic, lightly and finely granular background with numerous red blood cells (RBCs) and acellular debris. Biochemical analysis of the fluid sampled identified a total protein level of less than 20 g/l, albumin less than 10 g/l, amylase and lipase values of 15,570 U/L and 1150 U/L were measured, respectively and a glucose concentration of 3.57 mmol/l.
On the day of surgical exploration, the dog was pre-medicated with medetomidine hydrochloride 1μg/kg (0.0004 mg/lb) (sedastart 1 mg/ml) and methadone 0.2 mg/kg (0.09 mg/lb) (synthadon 10 mg/ml).Footnote 5 She was co-induced using a combination of ketamine 1 mg/kg (0.45 mg/lb) (ketamidor 100 mg /ml)Footnote 6 and propofol 1 mg /kg (0.45 mg/lb) (propofol-lipuro 10 mg/ml). An appropriate plane of anaesthesia was maintained using sevoflourane in oxygen. As additional analgesia she was administered a morphine epidural at 0.2 mg/kg (0.9 mg/lb) diluted in 5 ml saline. A fentanyl (fentadon 50μg/ml)Footnote 7 continuous rate infusion (CRI) at a rate of 1-2μg/kg/hr. (0.0004–0.0008 mg/lb./hr), following a loading dose of 2μg/kg (0.0008 mg/lb) IV and Lidocaine (lidocaine hydrochloride 5% solution)Footnote 8 CRI at a rate of 1–3 mg/kg/hr. (0.45–1.3 mg/lb./hr) following a loading dose of 2 mg/kg (1.3 mg/lb) IV were also used as adjunctive analgesia based on her nociceptive response to surgery, as deemed appropriate by the attending anaesthetist.
A standard ventral midline coeliotomy was performed from the xiphoid process to the pubis. The large ovoid structure was identified in the cranial mid-abdomen, consistent with the computed tomographic description of location and was confirmed to arise from the pancreas, at the junction between the left and the right limbs. The right limb of the pancreas was grossly normal and present within its physiological anatomical location. The left limb of the pancreas was oedematous and confluent with the surface of the mass. There was minimal adhesion of the mass to the remaining intra-abdominal structures. A partial pancreatectomy, the left limb was performed to allow complete removal of the cystic structure, en-bloc (Figs. 2 and 3).
Additional procedures performed, included ovariectomy, repair of the non-reducible umbilical hernia and the placement of an oesphagostomy feeding tube, due to risk of likely development of pancreatitis subsequent to surgery. No intra-operative complications were encountered. Abdominal closure was performed using 2.0 polydioxanone (2.0 PDS, Ethicon)Footnote 9 for the external rectus sheath in a simple continuous pattern, 3.0 poliglycapone (3.0 Monocryl 3.0, Ethicon)Footnote 10 for the subcutis and the 3.0 Nylon (3.0 Ethilon, Ethicon)Footnote 11 for cutaneous cruciate sutures.
The entire mass was submitted to the institutional anatomic pathology department and sections of the wall (Fig. 3) of the mass were subsequently processed and sectioned for histopathological assessment. Histopathological assessment identified a thick fibromuscular wall lined by a well regimented hyperplastic tall columnar epithelium was confirmed with basally located round to ovoid nuclei featuring fine chromatin stippling and abundant apically located and surface mucin. A small focus of normal appearing pancreatic tissue was also noted intimately associated with the cyst wall in one submitted section (Fig. 4). This picture was captured using an Olympus EP50 microscope digital camera mounted on an Olympus BX50 microscope. The lesion was photographed at a magnification of × 400. The diagnosis of a true pancreatic cyst was confirmed and thought to be congenital in nature and derived from the larger tributaries of the pancreatic ductular system.
The dog recovered uneventfully from anaesthesia and was maintained in the hospital intensive care unit overnight. Within 12 h of surgery finish, the dog was eating and drinking voluntarily, and the oesophagostomy feeding tube was not employed. Post-operative analgesia was provided via a continuation of the fentanyl (fentadon 50μg/ml)Footnote 12 and lidocaine (lidocaine hydrochloride 5% solution)Footnote 13 CRI for the initial hours after surgery and once discontinued maintained on methadone 0.2 mg/kg (0.09 mg/lb) (synthadon 10 mg/ml)Footnote 14 IV if deemed painful according to the Glasgow Pain scale [7], which in this case was only given once.
The dog was discharged from hospital three days post-operatively with orally administered non-steroidal anti-inflammatory medication, meloxicam 0.1 mg/kg (0.045 mg/lb) once daily (metacam 1.5 mg/ml).Footnote 15 She also had instructions including exercise modification and wound care advice. A twenty-nine month follow-up was available for the patient via telephone conversation with the owners. Her owners reported no abnormalities, no clinical signs and described her as a normal dog.